REGENERON PHARMACEUTICALS, INC. Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in REGENERON PHARMACEUTICALS, INC. for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | Sanofi | Sell | S | 489.65 | 128,914 | 63,123,153 | 20,421,899 | 20.6 M to 20.4 M (-0.63 %) | |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 30.63 | 150,000 | 4,594,500 | 0 | |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Option Exercise | M | 30.63 | 96,736 | 2,963,024 | 150,000 | |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 486.31 | 7 | 3,404 | 517,799 | 517.8 K to 517.8 K (0.00 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 485.63 | 1,693 | 822,172 | 517,806 | 519.5 K to 517.8 K (-0.33 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 484.72 | 345 | 167,228 | 519,499 | 519.8 K to 519.5 K (-0.07 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 483.80 | 355 | 171,749 | 519,844 | 520.2 K to 519.8 K (-0.07 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 481.68 | 100 | 48,168 | 520,199 | 520.3 K to 520.2 K (-0.02 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 480.34 | 60 | 28,820 | 520,299 | 520.4 K to 520.3 K (-0.01 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 479.60 | 1,651 | 791,820 | 520,359 | 522 K to 520.4 K (-0.32 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 478.43 | 1,469 | 702,814 | 522,010 | 523.5 K to 522 K (-0.28 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 477.50 | 4,735 | 2,260,963 | 523,479 | 528.2 K to 523.5 K (-0.90 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 476.51 | 7,197 | 3,429,442 | 528,214 | 535.4 K to 528.2 K (-1.34 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 475.43 | 4,223 | 2,007,741 | 535,411 | 539.6 K to 535.4 K (-0.78 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 474.52 | 7,060 | 3,350,111 | 539,634 | 546.7 K to 539.6 K (-1.29 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 473.39 | 8,024 | 3,798,481 | 546,694 | 554.7 K to 546.7 K (-1.45 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 472.56 | 10,270 | 4,853,191 | 554,718 | 565 K to 554.7 K (-1.82 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 471.34 | 5,258 | 2,478,306 | 564,988 | 570.2 K to 565 K (-0.92 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 470.48 | 5,531 | 2,602,225 | 570,246 | 575.8 K to 570.2 K (-0.96 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 469.46 | 7,250 | 3,403,585 | 575,777 | 583 K to 575.8 K (-1.24 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 468.49 | 8,542 | 4,001,842 | 583,027 | 591.6 K to 583 K (-1.44 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 467.53 | 10,023 | 4,686,053 | 591,569 | 601.6 K to 591.6 K (-1.67 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 466.58 | 11,916 | 5,559,767 | 601,592 | 613.5 K to 601.6 K (-1.94 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 465.45 | 7,068 | 3,289,801 | 613,508 | 620.6 K to 613.5 K (-1.14 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 464.59 | 5,099 | 2,368,944 | 620,576 | 625.7 K to 620.6 K (-0.81 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 463.54 | 5,463 | 2,532,319 | 625,675 | 631.1 K to 625.7 K (-0.87 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 462.43 | 3,317 | 1,533,880 | 631,138 | 634.5 K to 631.1 K (-0.52 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Sell | S | 461.79 | 1,159 | 535,215 | 634,455 | 635.6 K to 634.5 K (-0.18 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 476.42 | 78,376 | 37,339,894 | 635,614 | 714 K to 635.6 K (-10.98 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 30.63 | 150,000 | 4,594,500 | 713,990 | 564 K to 714 K (+26.60 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Payment of Exercise | F | 476.42 | 50,545 | 24,080,649 | 563,990 | 614.5 K to 564 K (-8.22 %) |
| Mar 11 2020 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President and Chief ... | Buy | M | 30.63 | 96,736 | 2,963,024 | 614,535 | 517.8 K to 614.5 K (+18.68 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 33.42 | 2,000 | 66,840 | 0 | |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 482.82 | 300 | 144,846 | 9,643 | 9.9 K to 9.6 K (-3.02 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 479.21 | 500 | 239,605 | 9,943 | 10.4 K to 9.9 K (-4.79 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 476.16 | 200 | 95,232 | 10,443 | 10.6 K to 10.4 K (-1.88 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 475.31 | 327 | 155,426 | 10,643 | 11 K to 10.6 K (-2.98 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 474.88 | 73 | 34,666 | 10,970 | 11 K to 11 K (-0.66 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 471.34 | 100 | 47,134 | 11,043 | 11.1 K to 11 K (-0.90 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 470.83 | 200 | 94,166 | 11,143 | 11.3 K to 11.1 K (-1.76 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 469.80 | 100 | 46,980 | 11,343 | 11.4 K to 11.3 K (-0.87 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 468.14 | 200 | 93,628 | 11,443 | 11.6 K to 11.4 K (-1.72 %) |
| Mar 10 2020 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 33.42 | 2,000 | 66,840 | 11,643 | 9.6 K to 11.6 K (+20.74 %) |